EP1357873A4 - THERAPEUTIC FILMOGENIC COMPOSITION AND TREATMENT SYSTEM THEREFOR - Google Patents

THERAPEUTIC FILMOGENIC COMPOSITION AND TREATMENT SYSTEM THEREFOR

Info

Publication number
EP1357873A4
EP1357873A4 EP02717290A EP02717290A EP1357873A4 EP 1357873 A4 EP1357873 A4 EP 1357873A4 EP 02717290 A EP02717290 A EP 02717290A EP 02717290 A EP02717290 A EP 02717290A EP 1357873 A4 EP1357873 A4 EP 1357873A4
Authority
EP
European Patent Office
Prior art keywords
film forming
treatment system
forming composition
system therefor
therapeutic film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02717290A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1357873A2 (en
Inventor
Israel Dvoretzky
John E Kuleza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1357873A2 publication Critical patent/EP1357873A2/en
Publication of EP1357873A4 publication Critical patent/EP1357873A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00Manicure or pedicure preparations
    • A61Q3/02Nail coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F7/02Compresses or poultices for effecting heating or cooling
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
EP02717290A 2001-01-09 2002-01-07 THERAPEUTIC FILMOGENIC COMPOSITION AND TREATMENT SYSTEM THEREFOR Withdrawn EP1357873A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26043001P 2001-01-09 2001-01-09
US260430P 2001-01-09
PCT/US2002/000282 WO2002055023A2 (en) 2001-01-09 2002-01-07 Therapeutic film forming composition and treatment system

Publications (2)

Publication Number Publication Date
EP1357873A2 EP1357873A2 (en) 2003-11-05
EP1357873A4 true EP1357873A4 (en) 2009-09-09

Family

ID=22989129

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02717290A Withdrawn EP1357873A4 (en) 2001-01-09 2002-01-07 THERAPEUTIC FILMOGENIC COMPOSITION AND TREATMENT SYSTEM THEREFOR

Country Status (14)

Country Link
EP (1) EP1357873A4 (zh)
JP (1) JP2004520337A (zh)
KR (1) KR20030072592A (zh)
CN (1) CN1281287C (zh)
AU (1) AU2002248308B2 (zh)
BR (1) BR0206307A (zh)
CA (1) CA2431236A1 (zh)
HU (1) HUP0501023A3 (zh)
IL (1) IL156458A0 (zh)
NO (1) NO20033123L (zh)
NZ (1) NZ526806A (zh)
PL (1) PL362920A1 (zh)
WO (1) WO2002055023A2 (zh)
ZA (1) ZA200305125B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
JP4863437B2 (ja) * 2005-07-07 2012-01-25 有限会社日本健康科学研究センター 浴用フィルム製剤
CA2633489C (en) * 2005-12-14 2013-09-24 Zars Pharma, Inc. Compositions and methods for treating dermatological conditions
JP5137175B2 (ja) * 2006-10-24 2013-02-06 有限会社日本健康科学研究センター フィルムガード製剤
EP1958613A1 (en) * 2007-02-15 2008-08-20 Polichem S.A. Dermal film-forming liquid formulations for drug release to skin
FR2937250B1 (fr) * 2008-10-21 2013-05-10 Fabre Pierre Dermo Cosmetique Solution filmogene a base d'uree pour le traitement du psorasis de l'ongle
US8771656B2 (en) * 2011-12-14 2014-07-08 Avon Products, Inc Long-lasting easy wash-off cosmetic compositions
WO2014018279A1 (en) * 2012-07-23 2014-01-30 Dow Global Technologies Llc Film composition for hard capsule shells
ES2506243T3 (es) * 2012-09-05 2014-10-13 Psoriasis+Creams Sweden Ab Composición para tratar la psoriasis
EP3096739B1 (en) * 2014-01-20 2021-04-14 Boehringer Ingelheim Animal Health USA Inc. Topical delivery formulation
CN104771781A (zh) * 2014-08-20 2015-07-15 江阴市柏御天谷生物医药有限公司 液体创面保护膜及其制备方法
CN105999393A (zh) * 2016-07-15 2016-10-12 蓝佳堂生物医药(福建)有限公司 一种液体创可贴及其制备方法
CN107320766A (zh) * 2016-12-08 2017-11-07 沈阳圣劳伦斯医疗器械有限公司 一种用于皮肤浅表创面保护的组合物
CN108785739A (zh) * 2018-08-13 2018-11-13 中国人民解放军南京军区福州总医院 一种多功能液体创可贴及其制备方法
CN110859989B (zh) * 2019-10-25 2021-06-22 天津冠勤医药科技有限公司 一种液体创可贴及其制备方法
CN111166932B (zh) * 2020-02-29 2021-01-26 海南妙音春制药有限公司 一种液体伤口喷剂敷料及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2188844A (en) * 1986-04-11 1987-10-14 Roehm Pharma Gmbh Pharmaceutical composition for the treatment of psoriasis
EP0913154A1 (de) * 1997-08-21 1999-05-06 Hoechst Marion Roussel Deutschland GmbH Antipsoriatisch wirksamer Nagellack
US5918590A (en) * 1995-06-29 1999-07-06 The Procter & Gamble Company Heat cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4212105A1 (de) * 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
US5534021A (en) * 1994-09-01 1996-07-09 Dvoretzky; Israel Heating pad for providing heat therapy

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2188844A (en) * 1986-04-11 1987-10-14 Roehm Pharma Gmbh Pharmaceutical composition for the treatment of psoriasis
US5918590A (en) * 1995-06-29 1999-07-06 The Procter & Gamble Company Heat cells
EP0913154A1 (de) * 1997-08-21 1999-05-06 Hoechst Marion Roussel Deutschland GmbH Antipsoriatisch wirksamer Nagellack

Also Published As

Publication number Publication date
JP2004520337A (ja) 2004-07-08
KR20030072592A (ko) 2003-09-15
CN1281287C (zh) 2006-10-25
IL156458A0 (en) 2004-01-04
PL362920A1 (en) 2004-11-02
BR0206307A (pt) 2004-07-20
HUP0501023A2 (en) 2007-02-28
WO2002055023A2 (en) 2002-07-18
ZA200305125B (en) 2004-10-01
CA2431236A1 (en) 2002-07-18
NZ526806A (en) 2006-03-31
NO20033123L (no) 2003-09-03
WO2002055023A3 (en) 2002-11-07
CN1514706A (zh) 2004-07-21
AU2002248308B2 (en) 2006-12-07
HUP0501023A3 (en) 2008-04-28
NO20033123D0 (no) 2003-07-08
EP1357873A2 (en) 2003-11-05

Similar Documents

Publication Publication Date Title
AU2002213357A1 (en) Variant igg3 rituxan r and therapeutic use thereof
EP1416961A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF A DISEASE
GB0111872D0 (en) Therapeutic agents and methods
AU2002245629A1 (en) Stabilized therapeutic and imaging agents
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
HUP0501023A2 (en) Therapeutic film forming composition and treatment system therefor
GB0110288D0 (en) Composition and treatment method
AU2002359618A1 (en) Medicinal compositions and therapeutic methods
HK1064042A1 (en) Medicines and medicinal kits
GB0001710D0 (en) Therapeutic treatment
HUP0401913A3 (en) Medicine for preventing and treating bromhidrosis
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
GB0119025D0 (en) Compounds and their therapeutic use
AU2002360696A8 (en) Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment for multiple sclerosis
AU2096002A (en) Therapeutic treatment
GB0111496D0 (en) Therapeutic systems and methods
GB0115780D0 (en) Therapeutic molecules and uses thereof
GB2376943B (en) Compounds and their therapeutic use
GB0112237D0 (en) Compounds and their therapeutic use
AU2595201A (en) Antiviral therapeutic composition and treatment
GB0128512D0 (en) Compounds and their therapeutic use
GB0201615D0 (en) Compounds and their therapeutic use
AU2001268762A1 (en) Treatment and therapy apparatus
GB0130191D0 (en) Therapeutic treatment
AU2002321141A1 (en) Pyrimidinoxyalkylpiperazines and their therapeutic use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030628

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20090807

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/70 20060101ALI20090803BHEP

Ipc: A61F 13/00 20060101AFI20030709BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20090902